Nifty
:
23850.90
Sensex
:
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)
Nifty
Sensex
:
:
23850.90
78782.24
-453.45 (-1.87%)
-606.82 (-0.76%)

Neogen Chemicals Ltd.

Chemicals

Rating :
N/A

BSE: 542665 | NSE: NEOGEN

NSE BSE
1650.25
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  1627.20
  •  1653.95
  •  1625.00
  •  1627.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  31206
  •  512.21
  •  2390.00
  •  1176.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 5,734.58
  • 153.41
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,115.62
  • 0.09%
  • 7.43

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.23%
  • 1.93%
  • 12.99%
  • FII
  • DII
  • Others
  • 8.17%
  • 21.55%
  • 4.13%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.46
  • 17.67
  • 12.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.14
  • 13.65
  • 4.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.51
  • 4.55
  • -7.22

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 76.42
  • 84.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 8.19
  • 7.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • 36.02
  • 40.29

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
179.95
164.88
9.14%
199.65
203.92
-2.09%
164.44
186.25
-11.71%
161.71
148.12
9.17%
Expenses
149.15
136.82
9.01%
163.86
171.33
-4.36%
144.15
156.11
-7.66%
135.79
123.87
9.62%
EBITDA
30.80
28.06
9.76%
35.79
32.59
9.82%
20.29
30.14
-32.68%
25.92
24.25
6.89%
EBIDTM
17.12%
17.02%
17.93%
15.98%
12.34%
16.18%
16.03%
16.37%
Other Income
1.57
1.79
-12.29%
2.21
1.73
27.75%
1.58
1.40
12.86%
1.89
0.42
350.00%
Interest
9.82
10.76
-8.74%
9.69
9.34
3.75%
10.52
6.66
57.96%
11.09
6.86
61.66%
Depreciation
6.81
5.48
24.27%
5.86
4.29
36.60%
5.74
4.14
38.65%
5.79
3.88
49.23%
PBT
15.74
13.61
15.65%
22.45
20.69
8.51%
5.61
20.74
-72.95%
10.93
13.93
-21.54%
Tax
4.29
3.88
10.57%
5.54
6.40
-13.44%
4.64
6.03
-23.05%
3.06
4.12
-25.73%
PAT
11.45
9.73
17.68%
16.91
14.29
18.33%
0.97
14.71
-93.41%
7.87
9.81
-19.78%
PATM
6.36%
5.90%
8.47%
7.01%
0.59%
7.90%
4.87%
6.62%
EPS
4.35
3.91
11.25%
6.42
5.74
11.85%
0.40
5.89
-93.21%
3.18
3.96
-19.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
705.75
690.67
686.18
487.25
336.41
306.12
239.06
161.15
110.07
100.30
83.92
Net Sales Growth
0.37%
0.65%
40.83%
44.84%
9.89%
28.05%
48.35%
46.41%
9.74%
19.52%
 
Cost Of Goods Sold
387.02
382.48
388.52
274.97
197.63
184.10
140.69
94.83
64.03
61.09
49.74
Gross Profit
318.73
308.19
297.66
212.28
138.78
122.02
98.37
66.32
46.04
39.21
34.18
GP Margin
45.16%
44.62%
43.38%
43.57%
41.25%
39.86%
41.15%
41.15%
41.83%
39.09%
40.73%
Total Expenditure
592.95
580.62
574.56
400.66
272.05
248.07
195.64
132.16
90.08
86.19
71.26
Power & Fuel Cost
-
31.91
33.79
20.30
9.49
8.97
7.64
6.21
5.08
4.94
4.71
% Of Sales
-
4.62%
4.92%
4.17%
2.82%
2.93%
3.20%
3.85%
4.62%
4.93%
5.61%
Employee Cost
-
62.00
46.82
31.50
20.07
17.25
11.15
8.70
5.45
4.54
4.76
% Of Sales
-
8.98%
6.82%
6.46%
5.97%
5.64%
4.66%
5.40%
4.95%
4.53%
5.67%
Manufacturing Exp.
-
56.14
58.96
52.21
32.31
24.91
22.55
15.21
7.86
6.98
5.92
% Of Sales
-
8.13%
8.59%
10.72%
9.60%
8.14%
9.43%
9.44%
7.14%
6.96%
7.05%
General & Admin Exp.
-
23.64
19.79
9.61
6.78
6.96
4.86
2.28
3.81
3.74
3.26
% Of Sales
-
3.42%
2.88%
1.97%
2.02%
2.27%
2.03%
1.41%
3.46%
3.73%
3.88%
Selling & Distn. Exp.
-
17.73
20.27
11.12
5.05
5.20
7.94
4.39
3.21
4.03
2.73
% Of Sales
-
2.57%
2.95%
2.28%
1.50%
1.70%
3.32%
2.72%
2.92%
4.02%
3.25%
Miscellaneous Exp.
-
6.72
6.41
0.95
0.72
0.67
0.80
0.54
0.64
0.88
2.73
% Of Sales
-
0.97%
0.93%
0.19%
0.21%
0.22%
0.33%
0.34%
0.58%
0.88%
0.18%
EBITDA
112.80
110.05
111.62
86.59
64.36
58.05
43.42
28.99
19.99
14.11
12.66
EBITDA Margin
15.98%
15.93%
16.27%
17.77%
19.13%
18.96%
18.16%
17.99%
18.16%
14.07%
15.09%
Other Income
7.25
7.47
4.45
1.07
0.14
0.10
0.51
0.66
0.31
0.16
1.00
Interest
41.12
42.06
28.94
19.08
13.77
11.93
11.94
10.42
7.52
4.79
4.65
Depreciation
24.20
22.87
16.20
11.69
6.90
5.24
2.84
1.85
1.31
1.00
0.94
PBT
54.73
52.59
70.93
56.89
43.83
40.98
29.15
17.39
11.47
8.48
8.06
Tax
17.53
17.12
21.06
12.44
12.88
12.44
8.31
6.44
3.82
3.30
2.98
Tax Rate
32.03%
32.55%
29.69%
21.87%
29.39%
30.36%
28.51%
37.03%
33.30%
38.92%
36.97%
PAT
37.20
35.65
49.97
44.63
31.33
28.54
20.84
10.95
7.64
5.18
5.08
PAT before Minority Interest
37.20
35.65
49.97
44.63
31.33
28.54
20.84
10.95
7.64
5.18
5.08
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
5.27%
5.16%
7.28%
9.16%
9.31%
9.32%
8.72%
6.79%
6.94%
5.16%
6.05%
PAT Growth
-23.36%
-28.66%
11.97%
42.45%
9.78%
36.95%
90.32%
43.32%
47.49%
1.97%
 
EPS
14.09
13.50
18.93
16.91
11.87
10.81
7.89
4.15
2.89
1.96
1.92

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
760.29
482.52
439.24
183.01
156.25
70.20
50.41
41.97
27.55
23.49
Share Capital
26.38
24.94
24.94
23.33
23.33
20.08
20.00
20.00
20.00
4.50
Total Reserves
733.91
457.58
414.30
159.68
132.91
50.12
30.41
21.97
7.55
18.99
Non-Current Liabilities
174.13
161.54
141.92
131.01
48.74
59.50
46.42
43.77
7.36
7.27
Secured Loans
124.23
129.08
121.52
116.10
30.36
37.75
22.84
21.84
2.53
3.46
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
12.85
15.65
14.92
2.24
1.27
Long Term Provisions
9.07
4.65
4.04
3.03
3.58
2.02
1.72
1.18
0.24
0.33
Current Liabilities
526.98
409.74
218.27
177.94
149.87
116.74
83.58
66.58
45.58
38.00
Trade Payables
144.60
156.55
98.88
66.08
35.85
42.82
36.67
30.98
21.84
16.36
Other Current Liabilities
135.11
45.15
41.06
23.96
10.50
6.31
4.98
5.17
3.31
3.06
Short Term Borrowings
242.50
204.20
76.20
85.79
101.94
65.17
41.22
30.15
20.06
18.34
Short Term Provisions
4.77
3.84
2.13
2.11
1.58
2.44
0.70
0.28
0.37
0.25
Total Liabilities
1,461.40
1,053.80
799.43
491.96
354.86
246.44
180.41
152.32
80.49
68.76
Net Block
495.62
347.45
285.13
126.71
110.54
82.82
67.05
56.32
17.43
13.19
Gross Block
560.53
389.65
313.41
143.51
120.45
87.51
68.90
59.78
19.58
14.34
Accumulated Depreciation
64.91
42.20
28.28
16.80
9.91
4.69
1.85
3.46
2.15
1.15
Non Current Assets
677.74
397.97
306.97
251.80
123.79
86.67
73.64
62.60
19.57
15.68
Capital Work in Progress
108.91
35.84
10.62
114.65
2.69
0.39
1.38
1.26
0.69
0.13
Non Current Investment
0.45
0.75
0.97
0.75
0.60
0.53
0.42
0.49
0.00
0.00
Long Term Loans & Adv.
69.06
11.18
10.25
9.69
9.95
2.94
2.48
2.27
1.45
2.33
Other Non Current Assets
3.70
2.75
0.00
0.00
0.00
0.00
2.31
2.26
0.00
0.04
Current Assets
783.66
655.83
492.46
240.16
231.06
159.76
106.77
89.72
60.92
53.08
Current Investments
0.00
76.06
80.76
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
382.44
292.97
194.59
114.03
129.87
72.38
49.99
40.01
31.76
24.30
Sundry Debtors
281.69
177.38
109.50
78.55
75.23
60.66
41.36
32.16
15.85
17.97
Cash & Bank
12.49
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40
Other Current Assets
107.04
5.96
7.97
3.61
24.48
24.70
13.60
14.47
10.83
8.40
Short Term Loans & Adv.
98.02
82.76
54.42
42.76
21.52
22.30
13.04
1.95
1.54
2.20
Net Current Assets
256.68
246.09
274.19
62.22
81.19
43.02
23.20
23.14
15.34
15.07
Total Assets
1,461.40
1,053.80
799.43
491.96
354.85
246.43
180.41
152.32
80.49
68.76

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
-29.15
-30.35
1.41
83.57
-34.55
-3.68
11.85
0.21
8.59
8.65
PBT
52.77
71.03
57.07
44.21
41.10
29.25
17.43
11.51
8.48
8.06
Adjustment
56.58
46.04
24.22
13.14
22.16
14.92
11.83
7.54
6.09
5.17
Changes in Working Capital
-128.75
-135.90
-70.08
36.59
-85.07
-42.34
-13.40
-14.94
-2.83
-2.03
Cash after chg. in Working capital
-19.40
-18.83
11.21
93.94
-21.81
1.83
15.85
4.11
11.74
11.20
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-9.75
-11.52
-9.80
-10.37
-12.74
-5.51
-4.00
-3.90
-3.15
-2.55
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-215.58
-94.46
-145.83
-134.57
-28.63
-20.09
-12.68
-32.92
-4.41
-1.79
Net Fixed Assets
-36.34
-101.46
-65.87
-135.02
-35.24
-17.62
-9.24
-40.77
-5.80
0.13
Net Investments
51.82
4.70
-80.76
0.00
0.00
0.00
0.00
-0.45
0.00
0.00
Others
-231.06
2.30
0.80
0.45
6.61
-2.47
-3.44
8.30
1.39
-1.92
Cash from Financing Activity
236.53
100.29
188.43
50.73
62.64
23.97
-0.43
33.32
-4.11
-6.25
Net Cash Inflow / Outflow
-8.20
-24.52
44.01
-0.27
-0.54
0.20
-1.26
0.61
0.07
0.61
Opening Cash & Equivalents
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40
1.79
Closing Cash & Equivalent
12.50
20.70
45.22
1.21
1.48
2.02
1.82
3.08
2.47
2.40

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
288.21
193.47
176.12
78.44
66.96
34.96
25.21
20.98
13.77
52.19
ROA
2.83%
5.39%
6.91%
7.40%
9.49%
9.77%
6.58%
6.57%
6.94%
7.72%
ROE
5.74%
10.84%
14.34%
18.47%
25.21%
34.56%
23.70%
22.00%
20.30%
23.61%
ROCE
9.49%
13.25%
14.33%
16.75%
21.88%
25.46%
22.82%
23.01%
26.11%
27.42%
Fixed Asset Turnover
1.45
1.95
2.13
3.04
3.34
3.27
2.55
3.06
6.42
6.33
Receivable days
121.30
76.30
70.43
70.02
71.35
72.86
81.81
72.13
56.68
68.93
Inventory Days
178.47
129.67
115.59
111.05
106.19
87.39
100.15
107.83
93.95
90.82
Payable days
143.69
119.98
109.49
94.13
55.38
74.63
92.30
110.77
84.02
84.47
Cash Conversion Cycle
156.08
85.99
76.54
86.94
122.15
85.63
89.66
69.20
66.61
75.28
Total Debt/Equity
0.52
0.75
0.51
1.18
0.88
1.71
1.63
1.65
0.96
1.03
Interest Cover
2.25
3.45
3.99
4.21
4.44
3.44
2.67
2.53
2.77
2.73

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Neogen Chemicals - Quarterly Results
    7th Aug 2024, 22:00 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.